Literature DB >> 15016942

Breast cancer recurrence: follow up after treatment for primary breast cancer.

N Hiramanek1.   

Abstract

BACKGROUND: Breast cancer will affect one in 12 Australian women in their lifetime. After potentially curative treatment, it is usual for patients to be followed up for many years. However, controversies surround follow up, and its value is uncertain. AIM: This study reviews the evidence and describes the role of routine follow up in the management of breast cancer in a tertiary hospital. By establishing how recurrence of breast cancer presents and identifying the proportion of patients with recurrence who were diagnosed as a consequence of regular follow up, the value of this system in detecting recurrence can be indirectly assessed.
DESIGN: A retrospective review was undertaken of all patients attending the radiotherapy outpatient clinic for treatment of invasive breast cancer in 1997. Hospital records were reviewed to ascertain patient and tumour characteristics, treatment received, site of recurrence and its mode of detection, whether patients were symptomatic at the time of recurrence, and whether they presented at a scheduled appointment.
RESULTS: Out of 286 patients who presented to the radiotherapy outpatient clinic, 220 were entered into the study. Recurrence was recorded in 42 patients (a complete dataset was available for 38 of these patients). In total, 74% (31/42) of recurrences were symptomatic, and 76% (32/42) presented at unscheduled appointments, the majority (17/32) of which were initiated by the patient. Only seven patients had asymptomatic recurrences.
CONCLUSION: Based on current evidence, long term routine hospital follow up after treatment for breast cancer appears to be inefficient in detecting recurrence.

Entities:  

Mesh:

Year:  2004        PMID: 15016942      PMCID: PMC1742945          DOI: 10.1136/pgmj.2003.010728

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  25 in total

Review 1.  Prognostic indicators in node-negative early stage breast cancer.

Authors:  W W Wong; S Vijayakumar; R R Weichselbaum
Journal:  Am J Med       Date:  1992-05       Impact factor: 4.965

2.  Effectiveness of routine and spontaneous follow-up visits for breast cancer.

Authors:  K Holli; M Hakama
Journal:  Eur J Cancer Clin Oncol       Date:  1989-02

3.  Breast conservation: long-term Australian data.

Authors:  J Boyages; C Bosch; A O Langlands; A M Bilous; B Barraclough; V J Gebski
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

4.  Characterization of node-negative breast cancer by clinico-pathologic and biologic factors.

Authors:  G Gasparini; P Bevilacqua; S Dal Fior; G A Panizzoni; S Favretto; A Visonà; S Meli
Journal:  Anticancer Res       Date:  1990 Jan-Feb       Impact factor: 2.480

5.  Screening for recurrent breast cancer--its effectiveness and prognostic value.

Authors:  R Tomin; W L Donegan
Journal:  J Clin Oncol       Date:  1987-01       Impact factor: 44.544

6.  Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up.

Authors:  M Rosselli Del Turco; D Palli; A Cariddi; S Ciatto; P Pacini; V Distante
Journal:  JAMA       Date:  1994-05-25       Impact factor: 56.272

7.  Follow-up after stage II breast cancer: a comparative study of relapsed versus nonrelapsed patients.

Authors:  H B Muss; M J McNamara; R A Connelly
Journal:  Am J Clin Oncol       Date:  1988-08       Impact factor: 2.339

8.  Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.

Authors:  B Fisher; M Bauer; R Margolese; R Poisson; Y Pilch; C Redmond; E Fisher; N Wolmark; M Deutsch; E Montague
Journal:  N Engl J Med       Date:  1985-03-14       Impact factor: 91.245

9.  Value of routine follow up of women treated for early carcinoma of the breast.

Authors:  J A Dewar; G R Kerr
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-23

10.  A retrospective study of earliest indicators of recurrence in patients on Eastern Cooperative Oncology Group adjuvant chemotherapy trials for breast cancer. A preliminary report.

Authors:  K J Pandya; E T McFadden; L A Kalish; D C Tormey; S G Taylor; G Falkson
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

View more
  4 in total

1.  Dynamic Optimal Strategy for Monitoring Disease Recurrence.

Authors:  Hong Li; Constantine Gatsonis
Journal:  Sci China Math       Date:  2012-08-01       Impact factor: 1.331

2.  Follow-up may not be beneficial after treatment of grade 1 breast cancer.

Authors:  M Kontos; D Allen; D T Trafalis; G Jones; H Garmo; L Holmberg; H Hamed
Journal:  Br J Surg       Date:  2009-09       Impact factor: 6.939

3.  Patterns in detection of recurrence among patients treated for breast cancer.

Authors:  Lena Saltbæk; Trine Allerslev Horsboel; Birgitte Vrou Offersen; Michael Andersson; Anne Sofie Friberg; Signe Korsgaard Skriver; Pernille Envold Bidstrup; Jens Overgaard; Christoffer Johansen; Susanne Oksbjerg Dalton
Journal:  Breast Cancer Res Treat       Date:  2020-08-06       Impact factor: 4.872

4.  Non-compliance with a postmastectomy radiotherapy guideline: decision tree and cause analysis.

Authors:  Amir R Razavi; Hans Gill; Hans Ahlfeldt; Nosrat Shahsavar
Journal:  BMC Med Inform Decis Mak       Date:  2008-09-21       Impact factor: 2.796

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.